Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Chemical Reviews

• Publication date

  2011-03-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/cr100223mPMID 21438608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The N348I Mutation at the Connection Subdomain of HIV-1 Reverse Transcriptase Decreases Binding to Nevirapine*

  2010cited by this paper
• Atomic evidence that modification of H-bonds established with amino acids critical for host-cell binding induces sterile immunity against malaria.

  2010cited by this paper
• Atomic fidelity of subunit-based chemically-synthesized antimalarial vaccine components.

  2010cited by this paper
• Merozoite surface proteins of the malaria parasite: the MSP1 complex and the MSP7 family.

  2010cited by this paper
• New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq

  2010cited by this paper
• 3D Analysis of the TCR/pMHCII Complex Formation in Monkeys Vaccinated with the First Peptide Inducing Sterilizing Immunity against Human Malaria

  2010cited by this paper
• Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3x Is Identified as a Minimal Chondroitin Sulfate A-binding Region*

  2010cited by this paper
• Proteomic profiling of Plasmodium falciparum through improved, semiquantitative two-dimensional gel electrophoresis.

  2010cited by this paper
• Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains?

  2010cited by this paper
• Systematic Genetic Analysis of the Plasmodium falciparum MSP7-Like Family Reveals Differences in Protein Expression, Location, and Importance in Asexual Growth of the Blood-Stage Parasite

  2010cited by this paper
• Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion

  2010cited by this paper
• Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.

  2010cited by this paper
• A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray

  2010cited by this paper
• Sequences of the Plasmodium falciparum cytoadherence-linked asexual protein 9 implicated in malaria parasite invasion to erythrocytes.

  2010cited by this paper
• Protein export in Plasmodium parasites: from the endoplasmic reticulum to the vacuolar export machine.

  2010cited by this paper
• Well-defined regions of the Plasmodium falciparum reticulocyte binding protein homologue 4 mediate interaction with red blood cell membrane.

  2010cited by this paper
• A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali.

  2009cited by this paper
• The future for blood‐stage vaccines against malaria

  2009cited by this paper
• The role of the Maurer's clefts in protein transport in Plasmodium falciparum.

  2009cited by this paper
• Structural Comparison of Two CSPG-Binding DBL Domains from the VAR2CSA Protein Important in Malaria during Pregnancy

  2009cited by this paper
• Structural insights into the protease-like antigen Plasmodium falciparum SERA5 and its noncanonical active-site serine.

  2009cited by this paper
• Fine mapping of Plasmodium falciparum ribosomal phosphoprotein PfP0 revealed sequences with highly specific binding activity to human red blood cells

  2009cited by this paper
• The Binding of Antigenic Peptides to HLA-DR Is Influenced by Interactions between Pocket 6 and Pocket 91

  2009cited by this paper
• Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.

  2009cited by this paper
• Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family.

  2009cited by this paper
• A Maurer's cleft-associated Plasmodium falciparum membrane-associated histidine-rich protein peptide specifically interacts with the erythrocyte membrane.

  2009cited by this paper
• Malaria parasite proteins that remodel the host erythrocyte

  2009cited by this paper
• Plasmodium genomics: latest milestone

  2009cited by this paper
• Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya

  2009cited by this paper
• MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum

  2009cited by this paper
• A multifunctional serine protease primes the malaria parasite for red blood cell invasion

  2009cited by this paper
• Synthetic peptides from conserved regions of the Plasmodium falciparum early transcribed membrane and ring exported proteins bind specifically to red blood cell proteins.

  2009cited by this paper
• The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria

  2009cited by this paper
• Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming ‘vaccine resistant malaria’

  2009cited by this paper
• HLA-DR: molecular insights and vaccine design.

  2009cited by this paper
• A novel protein export machine in malaria parasites

  2009cited by this paper
• Vaccinating with the genome: a Sisyphean task?

  2009cited by this paper
• Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils.

  2009cited by this paper
• Alanine Mutagenesis of the Primary Antigenic Escape Residue Cluster, C1, of Apical Membrane Antigen 1

  2009cited by this paper
• Immunity to malaria: more questions than answers

  2008cited by this paper
• Formation of the Food Vacuole in Plasmodium falciparum: A Potential Role for the 19 kDa Fragment of Merozoite Surface Protein 1 (MSP119)

  2008cited by this paper
• Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A

  2008cited by this paper
• HLA-DR allele reading register shifting is associated with immunity induced by SERA peptide analogues.

  2008cited by this paper
• Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine.

  2008cited by this paper
• Structural characterisation of sporozoite components for a multistage, multi-epitope, anti-malarial vaccine.

  2008cited by this paper
• Characterizing the Mycobacterium tuberculosis Rv2707 protein and determining its sequences which specifically bind to two human cell lines

  2008cited by this paper
• Proteomic Profiling of Plasmodium Sporozoite Maturation Identifies New Proteins Essential for Parasite Development and Infectivity

  2008cited by this paper
• Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC.

  2008cited by this paper
• Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.

  2008cited by this paper
• Apical membrane antigen 1: a malaria vaccine candidate in review.

  2008cited by this paper
• The Structure of a Chondroitin Sulfate-binding Domain Important in Placental Malaria

  2008cited by this paper
• Peptide length significantly influences in vitro affinity for MHC class II molecules

  2008cited by this paper
• Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2.

  2008cited by this paper
• Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

  2008cited by this paper
• A combined transcriptome and proteome survey of malaria parasite liver stages

  2008cited by this paper
• Shifting the polarity of some critical residues in malarial peptides' binding to host cells is a key factor in breaking conserved antigens' code of silence.

  2008cited by this paper
• Profiling humoral immune responses to P. falciparum infection with protein microarrays

  2008cited by this paper
• Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design.

  2008cited by this paper
• Identification of Plasmodium falciparum RhopH3 protein peptides that specifically bind to erythrocytes and inhibit merozoite invasion

  2008cited by this paper
• Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria

  2008cited by this paper
• A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach

  2008cited by this paper
• Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.

  2008cited by this paper
• Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum.

  2008cited by this paper
• Exported Proteins Required for Virulence and Rigidity of Plasmodium falciparum-Infected Human Erythrocytes

  2008cited by this paper
• Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines

  2008cited by this paper
• Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan

  2008cited by this paper
• Spatial dissection of the cis‐ and trans‐Golgi compartments in the malaria parasite Plasmodium falciparum

  2008cited by this paper
• Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.

  2007cited by this paper
• Epigenetic Silencing of Plasmodium falciparum Genes Linked to Erythrocyte Invasion

  2007cited by this paper
• Identifying merozoite surface protein 4 and merozoite surface protein 7 Plasmodium falciparum protein family members specifically binding to human erythrocytes suggests a new malarial parasite-redundant survival mechanism.

  2007cited by this paper
• Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.

  2007cited by this paper
• Structural modifications to a high-activity binding peptide located within the PfEMP1 NTS domain induce protection against P. falciparum malaria in Aotus monkeys

  2007cited by this paper
• Open Access Research

  2007cited by this paper
• Intercountry adoption

  2007cited by this paper
• Structural basis of antigenic escape of a malaria vaccine candidate

  2007cited by this paper
• The Mycobacterium tuberculosis membrane protein Rv2560 − biochemical and functional studies

  2007cited by this paper
• Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes.

  2007cited by this paper
• Merozoite surface protein 2 of Plasmodium falciparum: expression, structure, dynamics, and fibril formation of the conserved N-terminal domain.

  2007cited by this paper
• Profiling the antibody immune response against blood stage malaria vaccine candidates.

  2007cited by this paper
• Invasion of host cells by malaria parasites: a tale of two protein families

  2007cited by this paper
• A pre-PEXEL histidine-rich protein II erythrocyte binding peptide as a new way for anti-malarial vaccine development.

  2007cited by this paper
• Functional, structural, and immunological compartmentalisation of malaria invasive proteins.

  2007cited by this paper
• Staff costs are to blame for NHS deficits, say MPs

  2006cited by this paper
• Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients.

  2006cited by this paper
• Interactions between Merozoite Surface Proteins 1, 6, and 7 of the Malaria Parasite Plasmodium falciparum*

  2006cited by this paper
• How TCRs bind MHCs, peptides, and coreceptors.

  2006cited by this paper
• Abundance of intrinsically unstructured proteins in P. falciparum and other apicomplexan parasite proteomes.

  2006cited by this paper
• Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB lineages

  2006cited by this paper
• Synthetic peptides from Plasmodium falciparum apical membrane antigen 1 (AMA-1) specifically interacting with human hepatocytes.

  2006cited by this paper
• Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain

  2006cited by this paper
• Contrasting signatures of selection on the Plasmodium falciparum erythrocyte binding antigen gene family.

  2006cited by this paper
• High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion.

  2006cited by this paper
• A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya

  2006cited by this paper
• The impact of DM on MHC class II–restricted antigen presentation can be altered by manipulation of MHC–peptide kinetic stability

  2006cited by this paper
• Plasmodium falciparum merozoite surface protein 6 (MSP-6) derived peptides bind erythrocytes and partially inhibit parasite invasion.

  2006cited by this paper
• MHC class II proteins and disease: a structural perspective

  2006cited by this paper
• Protective cellular immunity against P. falciparum malaria merozoites is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex.

  2006cited by this paper
• Developmental Biology of Sporozoite-Host Interactions in Plasmodium falciparum Malaria: Implications for Vaccine Design

  2006cited by this paper
• Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB lineages

  2006cited by this paper
• Structure and inter-domain interactions of domain II from the blood-stage malarial protein, apical membrane antigen 1.

  2005cited by this paper

• Design and Expression of Fasciola hepatica Multiepitope Constructs Using mRNA Vaccine Technology

  2025cites this paper
• Developing Anti-Babesia bovis Blood Stage Vaccines: A New Perspective Regarding Synthetic Vaccines

  2023cites this paper
• Peptide-pulsed dendritic cells' immunomodulating effect regarding Mycobacterium tuberculosis growth in macrophages.

  2023cites this paper
• Identification of Babesia bovis MSA-1 functionally constraint regions capable of binding to bovine erythrocytes.

  2022cites this paper
• A Sporothrix spp enolase derived multi-epitope vaccine confers protective response in BALB/c mice challenged with Sporothrix brasiliensis.

  2022cites this paper
• SM-COLSARSPROT: Highly Immunogenic Supramutational Synthetic Peptides Covering the World’s Population

  2022cites this paper
• Stereo electronic principles for selecting fully-protective, chemically-synthesised malaria vaccines

  2022influential citation
• MHCBI: a pipeline for calculating peptide-MHC binding energy using semi-empirical quantum mechanical methods with explicit/implicit solvent models

  2021cites this paper
• Mycobacterium tuberculosis Rv0292 Protein Peptides Could be Included in a Synthetic Anti-tuberculosis Vaccine

  2021cites this paper
• The First Chemically-Synthesised, Highly Immunogenic Anti-SARS-CoV-2 Peptides in DNA Genotyped Aotus Monkeys for Human Use

  2021cites this paper
• T Cell Peptides Derived from Invasive Stages of Schistosoma mansoni as Potential Schistosomiasis Vaccine

  2021cites this paper
• Major Histocompatibility Complex Class II (DRB3) Genetic Diversity in Spanish Morucha and Colombian Normande Cattle Compared to Taurine and Zebu Populations

  2020cites this paper
• Una hoja de ruta para la Vacuna COVID 19 en Colombia, un reto posible

  2020cites this paper
• From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax

  2020influential citation
• Plasmodium falciparum pre-erythrocytic stage vaccine development

  2020cites this paper
• Exploring the Modulation of Immune Response and Oxidative Stress of Intracellular Pathogens Using Nanoparticles Encapsulating Drugs

  2020cites this paper
• The molecular basis for peptide-based antimalarial vaccine development targeting erythrocyte invasion by P. falciparum.

  2020cites this paper
• Antibodies targeting Mycobacterium tuberculosis peptides inhibit mycobacterial entry to infection target cells.

  2020cites this paper
• Malaria: Paving the way to developing peptide-based vaccines against invasion in infectious diseases.

  2020cites this paper
• Evaluating the immunogenicity of chemically-synthesised peptides derived from foot-and-mouth disease VP1, VP2 and VP3 proteins as vaccine candidates.

  2020cites this paper
• Plasmodium falciparum Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines

  2019cites this paper
• Specific Binding Peptides from Rv3632: A Strategy for Blocking Mycobacterium tuberculosis Entry to Target Cells?

  2019cites this paper
• Revisión de estudios pre-clínicos de candidatos a vacuna contra la malaria causada por Plasmodium falciparum

  2019cites this paper
• Babesia bovis: Actualidad del desarrollo de una vacuna

  2019cites this paper
• Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

  2019influential citation
• Assessing Peptide Binding to MHC II: An Accurate Semiempirical Quantum Mechanics Based Proposal

  2019cites this paper
• Towards designing a synthetic antituberculosis vaccine: The Rv3587c peptide inhibits mycobacterial entry to host cells.

  2018cites this paper
• Specific β-Turns Precede PPIIL Structures Binding to Allele-Specific HLA-DRβ1* PBRs in Fully-Protective Malaria Vaccine Components

  2018cites this paper
• Mycobacterium tuberculosis H37Rv LpqG Protein Peptides Can Inhibit Mycobacterial Entry through Specific Interactions

  2018cites this paper
• Plasmodium vivax Pv12 B-cell epitopes and HLA-DRβ1*-dependent T-cell epitopes in vitro antigenicity

  2018cites this paper
• The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile

  2018cites this paper
• The role of pi-interactions and hydrogen bonds in fully protective synthetic malaria vaccine development.

  2017cites this paper
• Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans.

  2017cites this paper
• Challenges and Perspectives in Malaria Treatment

  2017cites this paper
• Critical role of HLA-DRβ* binding peptides' peripheral flanking residues in fully-protective malaria vaccine development.

  2017cites this paper
• Determinación del proteoma de la cepa VCG-1 de Plasmodium Vivax y caracterización de moléculas candidatas para su inclusión en el desarrollo de una vacuna

  2017cites this paper
• Entwicklung synthetischer Vakzine auf Peptidbasis gegen Malaria

  2017cites this paper
• Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective

  2017influential citation
• Identifying and characterising PPE7 (Rv0354c) high activity binding peptides and their role in inhibiting cell invasion

  2017cites this paper
• PvGAMA reticulocyte binding activity: predicting conserved functional regions by natural selection analysis

  2017cites this paper
• What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?

  2017cites this paper
• Functionally relevant proteins in Plasmodium falciparum host cell invasion.

  2017cites this paper
• Characterization of the malaria parasite protein PfTip, a novel invasion-related protein.

  2016cites this paper
• Cell‐Peptide Specific Interaction Can Inhibit Mycobacterium tuberculosis H37Rv Infection

  2016influential citation
• Mycobacterium tuberculosis PE9 protein has high activity binding peptides which inhibit target cell invasion.

  2016cites this paper
• Malaria Parasite Survival Depends on Conserved Binding Peptides' Critical Biological Functions.

  2016cites this paper
• TCR-contacting residues orientation and HLA-DRβ* binding preference determine long-lasting protective immunity against malaria.

  2016cites this paper
• The Malaria Parasite's Achilles' Heel: Functionally-relevant Invasion Structures.

  2016cites this paper
• The Next Vaccine Generation Against Malaria: Structurally Modulated Plasmodium Antigens

  2016cites this paper
• Genetics and Vaccinology

  2015cites this paper
• Determining the Plasmodium vivax VCG-1 strain blood stage proteome.

  2015cites this paper
• Immune protection-inducing protein structures (IMPIPS) against malaria: the weapons needed for beating Odysseus.

  2015cites this paper
• Recent advances in the development of a chemically synthesised anti-malarial vaccine

  2015influential citation
• IMPIPS: The Immune Protection-Inducing Protein Structure Concept in the Search for Steric-Electron and Topochemical Principles for Complete Fully-Protective Chemically Synthesised Vaccine Development

  2015influential citation
• Vaccines – Recent advances and clinical trials

  2015cites this paper
• Mce4F Mycobacterium tuberculosis protein peptides can inhibit invasion of human cell lines.

  2015cites this paper
• Genetics and Vaccines in the Era of Personalized Medicine

  2015cites this paper
• The Plasmodium vivax rhoptry neck protein 5 is expressed in the apical pole of Plasmodium vivax VCG-1 strain schizonts and binds to human reticulocytes

  2015cites this paper
• Gauche(+) side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine.

  2014cites this paper
• Plasmodium falciparum rhoptry neck protein 5 peptides bind to human red blood cells and inhibit parasite invasion.

  2014cites this paper
• Using the PfEMP1 Head Structure Binding Motif to Deal a Blow at Severe Malaria

  2014influential citation
• Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine

  2014influential citation
• Production of an epitope-specific antibody using recombinant repetitive oligonucleotides

  2014cites this paper
• Specific Interaction between Mycobacterium tuberculosis Lipoprotein‐derived Peptides and Target Cells Inhibits Mycobacterial Entry In Vitro

  2014cites this paper
• Synthesis of carbohydrate-functionalised sequence-defined oligo(amidoamine)s by photochemical thiol-ene coupling in a continuous flow reactor.

  2013cites this paper
• The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts.

  2013cites this paper
• Reticulocytes: Plasmodium vivax target cells

  2013cites this paper
• Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion.

  2013cites this paper
• Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bonds

  2013influential citation
• Characterizing PvARP, a novel Plasmodium vivax antigen

  2013cites this paper
• Rv1268c protein peptide inhibiting Mycobacterium tuberculosis H37Rv entry to target cells.

  2013cites this paper
• The high immunogenicity induced by modified sporozoites' malarial peptides depends on their phi (ϕ) and psi (ψ) angles.

  2012cites this paper
• Phi (Φ) and psi (Ψ) angles involved in malarial peptide bonds determine sterile protective immunity.

  2012cites this paper
• Vaccines against Plasmodium vivax: a research challenge

  2012cites this paper
• The role of amino acid electron-donor/acceptor atoms in host-cell binding peptides is associated with their 3D structure and HLA-binding capacity in sterile malarial immunity induction.

  2012cites this paper
• Steric-electronic effects in malarial peptides inducing sterile immunity.

  2012cites this paper
• Towards the development of a fully protective Plasmodium falciparum antimalarial vaccine

  2012cites this paper
• Protective immunity provided by a new modified SERA protein peptide: its immunogenetic characteristics and correlation with 3D structure

  2011cites this paper
• Synthetic peptides from two Pf sporozoite invasion-associated proteins specifically interact with HeLa and HepG2 cells.

  2011cites this paper
• Identificación de la proteína del cuello de las roptrias 2 (RON2) de plasmodium vivax

  2011cites this paper
• Immunity in toxoplasmosis, the new players

  2011cites this paper
• 3D structure and immunogenicity of Plasmodium falciparum sporozoite induced associated protein peptides as components of fully-protective anti-malarial vaccine.

  2011cites this paper
• Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine.

  2011cites this paper